[go: up one dir, main page]

WO2009069219A1 - 血中尿酸値低減作用を有する乳酸菌 - Google Patents

血中尿酸値低減作用を有する乳酸菌 Download PDF

Info

Publication number
WO2009069219A1
WO2009069219A1 PCT/JP2007/073108 JP2007073108W WO2009069219A1 WO 2009069219 A1 WO2009069219 A1 WO 2009069219A1 JP 2007073108 W JP2007073108 W JP 2007073108W WO 2009069219 A1 WO2009069219 A1 WO 2009069219A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
acid bacteria
purine body
uric acid
acid level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/073108
Other languages
English (en)
French (fr)
Inventor
Hiroshi Tsuboi
Noriko Kaneko
Akina Satou
Yoshinobu Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020107013960A priority Critical patent/KR101385864B1/ko
Priority to CA2718157A priority patent/CA2718157C/en
Priority to CN2007801022788A priority patent/CN101932697B/zh
Priority to KR1020147004136A priority patent/KR101450511B1/ko
Priority to EP12002386.6A priority patent/EP2476747B1/en
Priority to HK11106655.0A priority patent/HK1152547B/xx
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Priority to US12/745,007 priority patent/US8460918B2/en
Priority to PCT/JP2007/073108 priority patent/WO2009069219A1/ja
Priority to EP07832808.5A priority patent/EP2221359B1/en
Publication of WO2009069219A1 publication Critical patent/WO2009069219A1/ja
Anticipated expiration legal-status Critical
Priority to US13/544,756 priority patent/US8541223B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/163—Oris
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

　プリン体存在下で各種乳酸菌を培養し、該プリン体の消費量および該プリン体分解物の生産量を測定し、プリン体分解能の顕著な複数の乳酸菌を選抜した。上記選抜によってプリン体分解能が高いと判断された乳酸菌を、プリン体含有飼料で飼育したラットに経口投与し、当該ラットの一般状態および血清尿酸値を測定し、乳酸菌投与による血清尿酸値への影響を検討した。その結果、血清尿酸値の上昇を有意に抑える乳酸菌：Lactobacillus gasseri OLL2959および Lactobacillus oris OLL2779を見出した。
PCT/JP2007/073108 2007-11-29 2007-11-29 血中尿酸値低減作用を有する乳酸菌 Ceased WO2009069219A1 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US12/745,007 US8460918B2 (en) 2007-11-29 2007-11-29 Lactic acid bacteria having action of lowering blood uric acid level
CA2718157A CA2718157C (en) 2007-11-29 2007-11-29 Lactobacillus gasseri capable of lowering blood uric acid level
CN2007801022788A CN101932697B (zh) 2007-11-29 2007-11-29 具有降低血中尿酸值作用的乳酸菌
KR1020147004136A KR101450511B1 (ko) 2007-11-29 2007-11-29 혈중 요산치 저감작용을 갖는 유산균
EP12002386.6A EP2476747B1 (en) 2007-11-29 2007-11-29 Lactic acid bacteria having action of lowering blood uric acid level
KR1020107013960A KR101385864B1 (ko) 2007-11-29 2007-11-29 혈중 요산치 저감작용을 갖는 유산균
EP07832808.5A EP2221359B1 (en) 2007-11-29 2007-11-29 Lactic acid bacteria having action of lowering blood uric acid level
HK11106655.0A HK1152547B (en) 2007-11-29 Lactic acid bacteria having action of lowering blood uric acid level
PCT/JP2007/073108 WO2009069219A1 (ja) 2007-11-29 2007-11-29 血中尿酸値低減作用を有する乳酸菌
US13/544,756 US8541223B2 (en) 2007-11-29 2012-07-09 Lactic acid bacteria having action of lowering blood uric acid level

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/073108 WO2009069219A1 (ja) 2007-11-29 2007-11-29 血中尿酸値低減作用を有する乳酸菌

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/745,007 A-371-Of-International US20070260582A1 (en) 2006-05-05 2007-05-07 Method and System for Visual Query Construction and Representation
US13/544,756 Division US8541223B2 (en) 2007-11-29 2012-07-09 Lactic acid bacteria having action of lowering blood uric acid level

Publications (1)

Publication Number Publication Date
WO2009069219A1 true WO2009069219A1 (ja) 2009-06-04

Family

ID=40678135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/073108 Ceased WO2009069219A1 (ja) 2007-11-29 2007-11-29 血中尿酸値低減作用を有する乳酸菌

Country Status (6)

Country Link
US (2) US8460918B2 (ja)
EP (2) EP2476747B1 (ja)
KR (2) KR101450511B1 (ja)
CN (1) CN101932697B (ja)
CA (1) CA2718157C (ja)
WO (1) WO2009069219A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016002757A1 (ja) * 2014-06-30 2016-01-07 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
WO2016080371A1 (ja) * 2014-11-18 2016-05-26 株式会社明治 プリン体の取り込み能を有する乳酸菌及びその用途
JP2016135151A (ja) * 2009-09-02 2016-07-28 株式会社明治 ラクトバチルス属乳酸菌の増殖促進剤及び／又は生残性向上剤
CN114574382A (zh) * 2022-01-17 2022-06-03 南京农业大学 具有预防或缓解高尿酸血症的鼠李糖乳杆菌fmb14及应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460918B2 (en) 2007-11-29 2013-06-11 Meiji Co., Ltd. Lactic acid bacteria having action of lowering blood uric acid level
JP5149305B2 (ja) 2007-11-30 2013-02-20 株式会社明治 血中尿酸値低減作用を有する乳酸菌
PL2457576T3 (pl) * 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
EA201491272A1 (ru) * 2012-05-29 2015-10-30 Данута Кружевска Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение
US9441210B2 (en) 2013-06-26 2016-09-13 Food Industry Research And Development Institute Method of reducing levels of uric acid
EP3165599A4 (en) * 2014-05-29 2017-12-27 Nitto Pharmaceutical Industries, Ltd. Novel lactic acid bacterium and composition including said lactic acid bacterium
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9636368B2 (en) * 2014-08-22 2017-05-02 Food Industry Research And Development Institute Strain of Lactobacillus rhamnosus and its metabolites for use in inhibiting xanthine oxidase and treating gout
TWI564389B (zh) * 2015-12-07 2017-01-01 New Bellus Enterprises Co Ltd 新穎乳酸菌、含有該乳酸菌之組合物及其用途
CN110079476B (zh) * 2019-04-24 2020-12-08 杭州娃哈哈科技有限公司 一株可降低血尿酸的发酵乳杆菌
CN110747146B (zh) * 2019-11-28 2022-05-27 微康益生菌(苏州)股份有限公司 具有降解尿酸作用的格氏乳杆菌lg08及其应用
CN111195266B (zh) * 2019-12-20 2022-11-01 微康益生菌(苏州)股份有限公司 具有缓解高尿酸作用的益生菌组合物及其应用
CN112458027B (zh) * 2020-12-16 2022-08-02 江南大学 一株格氏乳杆菌及其缓解和治疗高尿酸血症的用途
CN112574917B (zh) * 2020-12-16 2022-08-09 无锡特殊食品与营养健康研究院有限公司 一株缓解高尿酸血症的鼠李糖乳杆菌ccfm1131
CN113854447B (zh) * 2021-08-10 2024-01-12 天津科技大学 一种枸杞益生菌发酵饮料
KR20230064553A (ko) 2021-10-29 2023-05-10 가톨릭대학교 산학협력단 요산 분해능을 가지는 재조합 균주 및 이의 용도
CN113999805B (zh) * 2021-12-06 2022-05-17 四川高福记生物科技有限公司 一种防治高尿酸血症的发酵乳杆菌及其组合物与应用
CN115478028B (zh) * 2022-09-13 2023-12-15 南昌大学 一株嗜酸乳杆菌f02及其制得的制剂和应用
CN115975876B (zh) * 2022-11-30 2024-04-19 黑龙江八一农垦大学 一种预防雏鹅痛风的益生菌及其应用
CN116024130B (zh) * 2022-12-13 2023-11-24 广西爱生生命科技有限公司 一株降血尿酸发酵乳杆菌a21215及其应用
CN118185825B (zh) * 2024-04-09 2024-09-27 朗恒科技集团有限公司 一株发酵乳杆菌mx-7及其应用
CN119286738B (zh) * 2024-12-12 2025-02-25 济南微生态生物医学省实验室 一株德氏乳杆菌jnl0010在制备降尿酸药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1038951A1 (en) * 1999-03-23 2000-09-27 Societe Des Produits Nestle S.A. Synthetic medium for cultivating lactobacillus and/or bifidobacteria
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
WO2006067940A1 (ja) 2004-12-01 2006-06-29 Meiji Dairies Corporation ヒトabo式血液型結合性乳酸菌
JP5237581B2 (ja) * 2006-05-31 2013-07-17 株式会社明治 血中尿酸値低減作用を有する乳酸菌
US8460918B2 (en) 2007-11-29 2013-06-11 Meiji Co., Ltd. Lactic acid bacteria having action of lowering blood uric acid level
JP5149305B2 (ja) 2007-11-30 2013-02-20 株式会社明治 血中尿酸値低減作用を有する乳酸菌

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
IKENAGA T. ET AL.: "Shokujisei Konyosan Kessho Model Rat no Kecchu Nyosanchi ni Oyobosu Nyusankin no Eikyo", NIPPON NOGEI KAGAKUKAI TAIKAI KOEN YOSHISHU, vol. 2004, 2004, pages 197, XP003027192 *
IKENAGA T. ET AL.: "Takai Purine Nucleoside Taishano o Yusuru Nyusankin no Shokujisei Konyosan Kessho Model Rat no Kecchu Nyosanchi ni Oyobosu Eikyo", THE JAPANESE SOCIETY OF NUTRITION AND FOOD SCIENCE SOKAI KOEN YOSHISHU, vol. 58, 2004, pages 318, XP003027191 *
OGAWA J. ET AL.: "Konyosan Kessho ni Yuko na Nyusankin ni okeru Purine-tai Taisha no Kaiseki", NIPPON NOGEI KAGAKUKAI TAIKAI KOEN YOSHISHU, vol. 2005, 2005, pages 244, XP003027190 *
See also references of EP2221359A4 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016135151A (ja) * 2009-09-02 2016-07-28 株式会社明治 ラクトバチルス属乳酸菌の増殖促進剤及び／又は生残性向上剤
WO2016002757A1 (ja) * 2014-06-30 2016-01-07 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
JPWO2016002757A1 (ja) * 2014-06-30 2017-04-27 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
WO2016080371A1 (ja) * 2014-11-18 2016-05-26 株式会社明治 プリン体の取り込み能を有する乳酸菌及びその用途
CN114574382A (zh) * 2022-01-17 2022-06-03 南京农业大学 具有预防或缓解高尿酸血症的鼠李糖乳杆菌fmb14及应用
CN114574382B (zh) * 2022-01-17 2023-06-27 南京农业大学 具有预防或缓解高尿酸血症的鼠李糖乳杆菌fmb14及应用

Also Published As

Publication number Publication date
EP2476747B1 (en) 2014-09-03
EP2221359A4 (en) 2011-11-02
KR20100103805A (ko) 2010-09-28
KR20140032503A (ko) 2014-03-14
HK1152547A1 (en) 2012-03-02
US20120308539A1 (en) 2012-12-06
CA2718157C (en) 2018-08-21
EP2221359A1 (en) 2010-08-25
EP2476747A1 (en) 2012-07-18
US20110014168A1 (en) 2011-01-20
US8460918B2 (en) 2013-06-11
CN101932697A (zh) 2010-12-29
KR101450511B1 (ko) 2014-10-15
KR101385864B1 (ko) 2014-04-17
EP2221359B1 (en) 2014-01-15
CA2718157A1 (en) 2009-06-04
US8541223B2 (en) 2013-09-24
CN101932697B (zh) 2012-08-29

Similar Documents

Publication Publication Date Title
WO2009069219A1 (ja) 血中尿酸値低減作用を有する乳酸菌
WO2009069704A1 (ja) 血中尿酸値低減作用を有する乳酸菌
WO2008108298A1 (ja) 内臓脂肪減少剤
WO2010011874A3 (en) Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp)
WO2007144770A8 (en) Bacterium
WO2014020138A3 (en) Feed additive composition
WO2010064930A8 (en) Use of lactic acid bacteria to treat or prevent eczema
WO2009103884A3 (fr) Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures
NZ613335A (en) Agent for inducing interferon production containing lactic acid bacteria
WO2013153071A3 (en) A nutritional composition
WO2010012408A3 (de) Mikroemulsion
WO2012074818A3 (en) Compositions and methods for 3-hydroxypropionic acid production
IN2012DN00760A (ja)
SI2046944T1 (sl) Meĺ anica mleäśnokislinskih bakterij za pripravo brezglutenskih peäśenih izdelkov
EP2062968A4 (en) BACTERIENSTAMM WITH ANTIALLERGIC ACTIVITY AND BEVERAGE, FOOD AND ANTIALLY ENERGY WITH BACTERIAL STEM CELL
WO2009013709A3 (en) Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
EP1941892A3 (en) Anti-allergy lactic acid bacteria
NZ628207A (en) Energy-rich liquid nutritional composition having improved organoleptic properties
WO2009057743A1 (ja) 乳酸菌含有抗アレルギー用飲料
MY166100A (en) Iron pyrophosphate composition
WO2007023476A3 (en) Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria
HK1205692A1 (en) Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
WO2011073769A3 (en) Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition
WO2007006970A3 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780102278.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07832808

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2718157

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007832808

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107013960

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12745007

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP